AB68-SSA1,1353,2020 (c) “Disability insurance policy” has the meaning given in s. 632.895 (1) (a).
AB68-SSA1,1353,2121 (d) “Prescription drug” has the meaning given in s. 450.01 (20)
AB68-SSA1,1353,2222 (e) “Self-insured health plan” has the meaning given in s. 632.85 (1) (c).
AB68-SSA1,1354,3 23(2) Application of discounts. A disability insurance policy that offers a
24prescription drug benefit or a self-insured health plan shall apply to any calculation
25of an out-of-pocket maximum and to any deductible of the policy or plan for an

1enrollee the amount that any discount provided by the manufacturer of a brand
2name drug reduces the cost sharing amount charged to an enrollee for that brand
3name drug.
AB68-SSA1,2996 4Section 2996. 632.863 of the statutes is created to read:
AB68-SSA1,1354,5 5632.863 Pharmaceutical representatives. (1) Definitions. In this section:
AB68-SSA1,1354,86 (a) “Health care professional” means a physician or other health care
7practitioner who is licensed to provide health care services or to prescribe
8pharmaceutical or biologic products.
AB68-SSA1,1354,109 (b) “Pharmaceutical” means a medication that may legally be dispensed only
10with a valid prescription from a health care professional.
AB68-SSA1,1354,1311 (c) “Pharmaceutical representative” means an individual who markets or
12promotes pharmaceuticals to health care professionals on behalf of a pharmaceutical
13manufacturer for compensation.
AB68-SSA1,1354,1714 (d) “Wholesale acquisition cost” means the most recently reported
15manufacturer list or catalog price for a brand-name drug or generic drug available
16to wholesalers or direct purchasers in the United States, before application of
17discounts, rebates, or reductions in price.
AB68-SSA1,1354,23 18(2) Licensure. (a) No individual may act as a pharmaceutical representative
19in this state without obtaining a pharmaceutical representative license. In order to
20obtain a license, an individual shall apply to the commissioner, on a form prescribed
21by the commissioner. A license issued under this paragraph shall be renewed on an
22annual basis. The application to obtain or renew a license shall include all of the
23following information:
AB68-SSA1,1354,2524 1. The applicant's full name, residence address and telephone number, and
25business address and telephone number.
AB68-SSA1,1355,1
12. A description of the type of work in which the applicant will engage.
AB68-SSA1,1355,22 3. The fee under s. 601.31 (1) (nv).
AB68-SSA1,1355,43 4. An attestation that the applicant meets the professional education
4requirements under sub. (3).
AB68-SSA1,1355,55 5. Proof that the applicant has paid any assessed penalties and fees.
AB68-SSA1,1355,66 6. Any other information required by the commissioner.
AB68-SSA1,1355,117 (b) The pharmaceutical representative shall report, in writing, to the
8commissioner any change to the information submitted on the application under par.
9(a) or any material change to the pharmaceutical representative's business
10operations or to any information provided under this section. The report shall be
11made no later than 4 business days after the change or material change occurs.
AB68-SSA1,1355,1312 (c) A pharmaceutical representative shall display his or her license during each
13visit with a health care professional.
AB68-SSA1,1355,18 14(3) Professional education requirements. (a) In order to become initially
15licensed under sub. (2) (a), a pharmaceutical representative shall complete a
16professional education course as determined by the commissioner. A pharmaceutical
17representative shall, upon request, provide the commissioner with proof of the
18coursework's completion.
AB68-SSA1,1355,2219 (b) In order to renew a license under sub. (2) (a), a pharmaceutical
20representative shall complete a minimum of 5 hours of continuing professional
21education courses. A pharmaceutical representative shall, upon request, provide the
22commissioner with proof of the coursework's completion.
AB68-SSA1,1356,223 (c) The professional education coursework required under pars. (a) and (b) shall
24include training in ethical standards, whistleblower protections, laws and rules

1applicable to pharmaceutical marketing, and other areas that the commissioner may
2identify by rule.
AB68-SSA1,1356,43 (d) The commissioner shall regularly designate courses that fulfill the
4requirements under this subsection and publish a list of the designated courses.
AB68-SSA1,1356,95 (e) The professional education coursework required under this subsection may
6not be provided by the employer of a pharmaceutical representative or be funded, in
7any way, by the pharmaceutical industry or a 3rd party funded by the
8pharmaceutical industry. A provider of a course designated under par. (d) shall
9disclose any conflict of interest.
AB68-SSA1,1356,13 10(4) Disclosure to commissioner. (a) No later than June 1 of each year, a
11pharmaceutical representative shall provide to the commissioner, in the manner
12prescribed by the commissioner, all of the following information from the previous
13calendar year:
AB68-SSA1,1356,1614 1. The total number of times the pharmaceutical representative contacted
15health care professionals in this state and the specialties of the health care
16professionals contacted.
AB68-SSA1,1356,2017 2. For each contact with a health care professional in this state, the location and
18duration of the contact, the pharmaceuticals for which the pharmaceutical
19representative provides information, and the value of any item, including a product
20sample, compensation, material, or gift, provided to the health care professional.
AB68-SSA1,1356,2321 (b) The commissioner shall publish the information provided under par. (a) on
22the commissioner's Internet site in a manner in which individual health care
23professionals are not identifiable by name or other identifiers.
AB68-SSA1,1357,4 24(5) Disclosure to health care professionals. During each contact with a
25health care professional, a pharmaceutical representative shall disclose the

1wholesale acquisition cost of any pharmaceutical for which the pharmaceutical
2representative provides information and the names of at least 3 generic prescription
3drugs from the same therapeutic class, or if 3 are not available, as many as are
4available for prescriptive use.